Brown Brothers Harriman & Co’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.9M | Sell |
84,298
-177
| -0.2% | -$74.8K | 0.14% | 105 |
|
|
2026
Q1 | $40M | Buy |
84,475
+80,429
| +1,988% | +$40.5M | 0.21% | 89 |
|
|
2025
Q4 | $1.89M | Buy |
4,046
+562
| +16% | +$261K | 0.01% | 288 |
|
|
2025
Q3 | $1.48M | Sell |
3,484
-148
| -4% | -$57.4K | 0.01% | 290 |
|
|
2025
Q2 | $1.39M | Buy |
3,632
+669
| +23% | +$241K | 0.01% | 280 |
|
|
2025
Q1 | $1.02M | Sell |
2,963
-59
| -2% | -$19K | 0.01% | 293 |
|
|
2024
Q4 | $907K | Buy |
3,022
+116
| +4% | +$40.5K | 0.01% | 314 |
|
|
2024
Q3 | $1.18M | Buy |
2,906
+4
| +0.1% | +$1.46K | 0.01% | 273 |
|
|
2024
Q2 | $932K | Buy |
2,902
+2,137
| +279% | +$694K | 0.01% | 282 |
|
|
2024
Q1 | $255K | Sell |
765
-9
| -1% | -$2.75K | ﹤0.01% | 483 |
|
|
2023
Q4 | $210K | Sell |
774
-8
| -1% | -$1.98K | ﹤0.01% | 482 |
|
|
2023
Q3 | $192K | Buy |
782
+416
| +114% | +$114K | ﹤0.01% | 491 |
|
|
2023
Q2 | $111K | Sell |
366
-54
| -13% | -$15K | ﹤0.01% | 572 |
|
|
2023
Q1 | $111K | Buy |
420
+37
| +10% | +$9.4K | ﹤0.01% | 589 |
|
|
2022
Q4 | $91.9K | Sell |
383
-3
| -0.8% | -$672 | ﹤0.01% | 609 |
|
|
2022
Q3 | $71K | Sell |
386
-27
| -7% | -$5.38K | ﹤0.01% | 663 |
|
|
2022
Q2 | $69K | Buy |
413
+47
| +13% | +$10.1K | ﹤0.01% | 650 |
|
|
2022
Q1 | $92K | Sell |
366
-6
| -2% | -$1.51K | ﹤0.01% | 650 |
|
|
2021
Q4 | $96 | Hold |
372
| – | – | ﹤0.01% | 595 |
|
|
2021
Q3 | $90 | Hold |
372
| – | – | ﹤0.01% | 581 |
|
|
2021
Q2 | $77 | Hold |
372
| – | – | ﹤0.01% | 598 |
|
|
2021
Q1 | $70 | Sell |
372
-178
| -32% | -$31.4K | ﹤0.01% | 588 |
|
|
2020
Q4 | $90K | Buy |
550
+336
| +157% | +$49.1K | ﹤0.01% | 575 |
|
|
2020
Q3 | $27K | Buy |
214
+199
| +1,327% | +$24.6K | ﹤0.01% | 654 |
|
|
2020
Q2 | $1K | Sell |
15
-10
| -40% | -$1.04K | ﹤0.01% | 936 |
|
|
2020
Q1 | $2K | Sell |
25
-3,790
| -99% | -$491K | ﹤0.01% | 927 |
|
|
2019
Q4 | $564K | Buy |
3,815
+2,729
| +251% | +$366K | ﹤0.01% | 290 |
|
|
2019
Q3 | $131K | Sell |
1,086
-92
| -8% | -$11.9K | ﹤0.01% | 500 |
|
|
2019
Q2 | $159K | Buy |
1,178
+1,138
| +2,845% | +$144K | ﹤0.01% | 432 |
|
|
2019
Q1 | $5K | Sell |
40
-9
| -18% | -$1.21K | ﹤0.01% | 901 |
|
|
2018
Q4 | $6K | Buy |
49
+40
| +444% | +$5.37K | ﹤0.01% | 758 |
|
|
2018
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 796 |
|
|
2018
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 794 |
|
|
2018
Q1 | $1K | Sell |
9
-68
| -88% | -$6.6K | ﹤0.01% | 769 |
|
|
2017
Q4 | $7K | Buy |
77
+32
| +71% | +$2.57K | ﹤0.01% | 802 |
|
|
2017
Q3 | $4K | Hold |
45
| – | – | ﹤0.01% | 695 |
|
|
2017
Q2 | $4K | Hold |
45
| – | – | ﹤0.01% | 710 |
|
|
2017
Q1 | $4K | Buy |
+45
| New | +$3.75K | ﹤0.01% | 735 |
|
Other funds holding HCA
Brown Brothers Harriman & Co's HCA Position: Q2 2026 in Review
Brown Brothers Harriman & Co reduced its HCA Healthcare (HCA) stake by 0.21% in Q2 2026, selling an estimated $74.8K and leaving 84,298 shares worth $32.9M. The position accounts for 0.14% of the portfolio, ranked #105.
Brown Brothers Harriman & Co first reported a position in HCA in Q1 2017 and has held it in 38 quarters since. The position peaked at $40M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Brown Brothers Harriman & Co held 84,298 shares of HCA Healthcare worth $32.9M as of Q2 2026.
- Brown Brothers Harriman & Co sold 177 HCA Healthcare shares in Q2 2026, an estimated $74.8K.
- HCA Healthcare made up 0.14% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #105 holding.
- Brown Brothers Harriman & Co first reported a position in HCA Healthcare in Q1 2017 and has held it in 38 quarters since.
- Brown Brothers Harriman & Co's HCA Healthcare position peaked at $40M in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.